Hedgehog signaling in lung cancer: from oncogenesis to cancer treatment resistance
E Giroux-Leprieur, A Costantini, VW Ding… - International journal of …, 2018 - mdpi.com
Hedgehog signaling pathway is physiologically activated during embryogenesis, especially
in lung development. It is also reactivated in many solid tumors. In lung cancer, Hedgehog …
in lung development. It is also reactivated in many solid tumors. In lung cancer, Hedgehog …
Role of GLI transcription factors in pathogenesis and their potential as new therapeutic targets
GLI transcription factors have important roles in intracellular signaling cascade, acting as the
main mediators of the HH-GLI signaling pathway. This is one of the major developmental …
main mediators of the HH-GLI signaling pathway. This is one of the major developmental …
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma
S Song, Q Chen, Y Li, G Lei, A Scott, L Huo, CY Li… - Gut, 2021 - gut.bmj.com
Objective Gastro-oesophageal cancers (GEC) are resistant to therapy and lead to poor
prognosis. The cancer stem cells (CSCs) and antiapoptotic pathways often confer therapy …
prognosis. The cancer stem cells (CSCs) and antiapoptotic pathways often confer therapy …
YAP1-mediated CDK6 activation confers radiation resistance in esophageal cancer–Rationale for the combination of YAP1 and CDK4/6 inhibitors in esophageal …
Purpose: Esophageal cancer is a lethal disease that is often resistant to therapy. Alterations
of YAP1 and CDK6 are frequent in esophageal cancer. Deregulation of both molecules may …
of YAP1 and CDK6 are frequent in esophageal cancer. Deregulation of both molecules may …
Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
S Song, Y Li, Y Xu, L Ma, M Pool Pizzi, J Jin… - Molecular …, 2020 - Wiley Online Library
Hippo/YAP1 signaling is a major regulator of organ size, cancer stemness, and aggressive
phenotype. Thus, targeting YAP1 may provide a novel therapeutic strategy for tumors with …
phenotype. Thus, targeting YAP1 may provide a novel therapeutic strategy for tumors with …
Linking cancer stem cell plasticity to therapeutic resistance-mechanism and novel therapeutic strategies in esophageal cancer
Esophageal cancer (EC) is an aggressive form of cancer, including squamous cell
carcinoma (ESCC) and adenocarcinoma (EAC) as two predominant histological subtypes …
carcinoma (ESCC) and adenocarcinoma (EAC) as two predominant histological subtypes …
GANT61 and lithium chloride inhibit the growth of head and neck cancer cell lines through the regulation of GLI3 processing by GSK3β
V Zubčić, N Rinčić, M Kurtović, D Trnski… - International journal of …, 2020 - mdpi.com
Several signaling pathways are aberrantly activated in head and neck squamous cell
carcinoma (HNSCC), including the Hedgehog-Gli (HH-GLI), WNT, EGFR, and NOTCH …
carcinoma (HNSCC), including the Hedgehog-Gli (HH-GLI), WNT, EGFR, and NOTCH …
Therapeutic strategies against cancer stem cells in esophageal carcinomas
Cancer stem cells (CSCs) in esophageal cancer have a key role in tumor initiation,
progression and therapy resistance. Novel therapeutic strategies to target CSCs are being …
progression and therapy resistance. Novel therapeutic strategies to target CSCs are being …
Cancer stem cells in esophageal squamous cell carcinoma
G Sun, Y Yang, J Liu, Z Gao, T Xu, J Chai, J Xu… - … -Research and Practice, 2022 - Elsevier
Esophageal squamous cell carcinoma (ESCC) is one of the most intractable challenges
among human diseases with poor prognosis and shortness of effective therapeutic options …
among human diseases with poor prognosis and shortness of effective therapeutic options …
Biomarkers for the prediction of esophageal cancer neoadjuvant chemoradiotherapy response: A systemic review
Y Li, J Liu, X Cai, H Li, Y Cheng, X Dong, W Yu… - Critical Reviews in …, 2021 - Elsevier
Neoadjuvant chemoradiotherapy followed by surgery has been established as the standard
treatment for locally advanced esophageal cancer. For patients with complete regression …
treatment for locally advanced esophageal cancer. For patients with complete regression …